Meta Platforms (META) is down 6.9% today. Here is some analysis on what might have caused this price movement.
Analysis: The drop appears tied to Meta raising its 2026 capital expenditure outlook, which can pressure near-term free cash flow and margins even when core advertising results are strong. Investors also seemed to look through the headline earnings strength given the quarter included a sizable tax-related benefit.
Details:
Sources:
Meta Investor Relations, SEC (8-K), Bloomberg
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$META Insider Trading Activity
$META insiders have traded $META stock on the open market 125 times in the past 6 months. Of those trades, 0 have been purchases and 125 have been sales.
Here’s a breakdown of recent trading of $META stock by insiders over the last 6 months:
- SUSAN J LI (Chief Financial Officer) has made 0 purchases and 24 sales selling 144,355 shares for an estimated $92,273,250.
- JAVIER OLIVAN (Chief Operating Officer) has made 0 purchases and 72 sales selling 27,622 shares for an estimated $17,612,839.
- ANDREW BOSWORTH (Chief Technology Officer) has made 0 purchases and 11 sales selling 24,842 shares for an estimated $15,127,520.
- JENNIFER NEWSTEAD (Chief Legal Officer) has made 0 purchases and 9 sales selling 4,668 shares for an estimated $2,978,422.
- ROBERT M KIMMITT has made 0 purchases and 6 sales selling 3,500 shares for an estimated $2,223,048.
- PEGGY ALFORD has made 0 purchases and 2 sales selling 993 shares for an estimated $657,370.
- AARON ANDERSON (Chief Accounting Officer) sold 726 shares for an estimated $429,501
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$META Hedge Fund Activity
We have seen 2,618 institutional investors add shares of $META stock to their portfolio, and 2,071 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AUTO-OWNERS INSURANCE CO removed 105,132,784 shares (-99.8%) from their portfolio in Q1 2026, for an estimated $58,898,539,580
- J. STERN & CO. LLP added 69,519,638 shares (+53305.2%) to their portfolio in Q4 2025, for an estimated $45,889,217,847
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 35,184,915 shares (-72.9%) from their portfolio in Q4 2025, for an estimated $23,225,210,542
- JPMORGAN CHASE & CO removed 10,859,259 shares (-19.8%) from their portfolio in Q4 2025, for an estimated $7,168,088,273
- FMR LLC removed 7,659,737 shares (-5.9%) from their portfolio in Q4 2025, for an estimated $5,056,115,796
- VANGUARD GROUP INC added 7,269,279 shares (+3.8%) to their portfolio in Q4 2025, for an estimated $4,798,378,375
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 6,101,761 shares (-99.0%) from their portfolio in Q4 2025, for an estimated $4,027,711,418
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$META Congressional Stock Trading
Members of Congress have traded $META stock 14 times in the past 6 months. Of those trades, 9 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $META stock by members of Congress over the last 6 months:
- SENATOR ANGUS S. KING JR. sold up to $15,000 on 02/13.
- REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 02/12.
- REPRESENTATIVE CLEO FIELDS has traded it 2 times. They made 2 purchases worth up to $350,000 on 02/03, 01/20 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/30 and 1 sale worth up to $15,000 on 12/24.
- REPRESENTATIVE RICK LARSEN purchased up to $15,000 on 01/07.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 12/29.
- SENATOR SHELLEY MOORE CAPITO purchased up to $15,000 on 11/13.
- REPRESENTATIVE JONATHAN L. JACKSON sold up to $15,000 on 11/11.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 10/31.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
$META Analyst Ratings
Wall Street analysts have issued reports on $META in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Argus Research issued a "Buy" rating on 02/02/2026
- B of A Securities issued a "Buy" rating on 01/29/2026
- Truist Securities issued a "Buy" rating on 01/29/2026
- Stifel issued a "Buy" rating on 01/29/2026
- Mizuho issued a "Outperform" rating on 01/29/2026
- Morgan Stanley issued a "Overweight" rating on 01/29/2026
- DA Davidson issued a "Buy" rating on 01/29/2026
To track analyst ratings and price targets for $META, check out Quiver Quantitative's $META forecast page.
$META Price Targets
Multiple analysts have issued price targets for $META recently. We have seen 27 analysts offer price targets for $META in the last 6 months, with a median target of $850.0.
Here are some recent targets:
- Michael Morris from Guggenheim set a target price of $850.0 on 04/23/2026
- Stephen Ju from UBS set a target price of $908.0 on 04/21/2026
- Andrew Boone from Citizens set a target price of $900.0 on 04/21/2026
- Justin Post from B of A Securities set a target price of $820.0 on 04/20/2026
- John Blackledge from TD Cowen set a target price of $820.0 on 04/16/2026
- Mark Kelley from Stifel set a target price of $805.0 on 04/13/2026
- Barton Crockett from Rosenblatt set a target price of $1015.0 on 04/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.